Double-blind randomized controlled clinical-trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate (vol 54, pg 2817, 2006)
Päätekijät: | Maini, R, Taylor, P, Szechinski, J, Pavelka, K, Broll, J, Balint, G, Emery, P, Raemen, F, Petersen, J, Smolen, J, Thomson, D, Kishimoto, T |
---|---|
Aineistotyyppi: | Journal article |
Julkaistu: |
2008
|
Samankaltaisia teoksia
-
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.
Tekijä: Maini, R, et al.
Julkaistu: (2006) -
Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA).
Tekijä: Maini, R, et al.
Julkaistu: (2003) -
Comparative effectiveness of tocilizumab with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
Tekijä: Javier Narváez, et al.
Julkaistu: (2015-01-01) -
UK malaria treatment guidelines (vol 54, pg 111, 2007)
Tekijä: Lalloo, D, et al.
Julkaistu: (2009) -
COMPARATIVE EVALUATION OF THE EFFICIENCY AND SAFETY OF TREATING CHILDREN WITH POLYARTICULARY JUVENILE IDIOPATHIC ARTHRITIS WITH METHOTREXATE AND WITH METHOTREXATE COMBINED WITH TOCILIZUMAB
Tekijä: V. A. Kel'tsev, et al.
Julkaistu: (2015-04-01)